Unknown NA INTERVENTIONAL 2-arm NCT04514822

Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 18F-FDG PET/CT in Patients With ESCC

Quantitative Evaluation of Metastatic Lymph Nodes With Dynamic 2-[18F]Fluoro-2-deoxy-glucose (18F-FDG) Positron Emission Tomography/Computed Tomography in Patients With Esophageal Squamous Cell Carcinoma

Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University

Conditions Esophageal Squamous Cell Carcinoma Positron Emission Tomography

Interventions Dynamic PET

Updated 6 times since 2020 Last updated: Feb 2, 2021 Started: Mar 1, 2019 Primary completion: Dec 30, 2022 Completion: Dec 30, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04514822, this NA trial focuses on Esophageal Squamous Cell Carcinoma and Positron Emission Tomography and remains ongoing. Sponsored by Fifth Affiliated Hospital, Sun Yat-Sen University, it has been updated 6 times since 2019, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown NA
Jul 2024 — Sep 2024 [monthly]

Unknown NA

Status: Unknown Status → Unknown
Feb 2024 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
Mar 2021 — Feb 2024 [monthly]

Recruiting NA
Jan 2021 — Mar 2021 [monthly]

Recruiting NA

▶ Show 1 earlier version

Sep 2020 — Jan 2021 [monthly]

Recruiting NA

First recorded

Mar 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fifth Affiliated Hospital, Sun Yat-Sen University

Data source: Fifth Affiliated Hospital, Sun Yat-Sen University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zhuhai, China